27,714 Stryker Corporation $SYK Shares Sold by Engineers Gate Manager LP

Key Points

• Engineers Gate Manager LP cut its Stryker stake by 96.1% in the second quarter, selling 27,714 shares and retaining 1,117 shares valued at approximately $352,000. Institutional investors and hedge funds collectively own 77.09% of SYK.
• Stryker shares opened at $272.11, near the company’s 12-month low of $267 and well below its 12-month high of $392.55. Despite the decline, analysts maintain a “Moderate Buy” consensus with an average price target of $374.42.
• Stryker exceeded quarterly earnings expectations, reporting $3.69 in EPS and $6.59 billion in revenue, while revenue increased 9.4% year over year. The company also declared a quarterly dividend of $0.88 per share, representing a 1.3% annualized yield.

Engineers Gate Manager LP decreased its stake in Stryker Corporation (NYSE:SYK - Free Report) by 96.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,117 shares of the medical technology company's stock after selling 27,714 shares during the quarter. Engineers Gate Manager LP's holdings in Stryker were worth $352,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Cidel Asset Management Inc. raised its position in Stryker by 6.9% in the 2nd quarter. Cidel Asset Management Inc. now owns 2,080 shares of the medical technology company's stock valued at $655,000 after purchasing an additional 135 shares during the last quarter. Plimoth Trust Co. LLC increased its stake in shares of Stryker by 1.6% in the second quarter. Plimoth Trust Co. LLC now owns 10,547 shares of the medical technology company's stock valued at $3,321,000 after buying an additional 171 shares in the last quarter. Capital Analysts LLC increased its stake in shares of Stryker by 6.1% in the second quarter. Capital Analysts LLC now owns 1,469 shares of the medical technology company's stock valued at $462,000 after buying an additional 85 shares in the last quarter. Pinnacle Wealth Management Advisory Group LLC raised its holdings in shares of Stryker by 3.2% in the second quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,497 shares of the medical technology company's stock valued at $471,000 after buying an additional 46 shares during the last quarter. Finally, Community Bank N.A. lifted its position in Stryker by 7.1% during the 2nd quarter. Community Bank N.A. now owns 7,551 shares of the medical technology company's stock worth $2,377,000 after buying an additional 502 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Stryker Price Performance

Shares of SYK stock opened at $272.11 on Friday. The firm has a market capitalization of $104.37 billion, a price-to-earnings ratio of 28.20, a price-to-earnings-growth ratio of 1.70 and a beta of 0.76. The company has a quick ratio of 1.33, a current ratio of 2.16 and a debt-to-equity ratio of 0.59. The firm has a fifty day moving average of $315.01 and a 200-day moving average of $319.18. Stryker Corporation has a 12-month low of $267.00 and a 12-month high of $392.55.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. The business had revenue of $6.59 billion during the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.Stryker's quarterly revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.13 EPS. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities research analysts forecast that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.3%. Stryker's dividend payout ratio (DPR) is presently 36.48%.

Analyst Ratings Changes

Several research firms have weighed in on SYK. Leerink Partners lowered their price objective on shares of Stryker from $410.00 to $407.00 and set an "outperform" rating for the company in a research report on Friday, June 5th. Canaccord Genuity Group reduced their target price on shares of Stryker from $400.00 to $385.00 and set a "buy" rating on the stock in a research report on Friday, September 18th. Raymond James Financial set a $370.00 price target on shares of Stryker in a research note on Friday, July 31st. TD Cowen lowered their price target on shares of Stryker from $355.00 to $298.00 and set a "hold" rating for the company in a report on Tuesday. Finally, BMO Capital Markets restated an "outperform" rating and issued a $317.00 price objective on shares of Stryker in a research report on Wednesday, September 9th. Eighteen equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, Stryker has a consensus rating of "Moderate Buy" and a consensus price target of $374.42.

Insider Buying and Selling

In other news, Director Ronda E. Stryker sold 300,000 shares of the firm's stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $335.90, for a total transaction of $100,770,000.00. Following the completion of the transaction, the director directly owned 2,301,375 shares of the company's stock, valued at $773,031,862.50. This trade represents a 11.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Debra King sold 826 shares of Stryker stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the completion of the sale, the insider owned 6,210 shares in the company, valued at $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 351,267 shares of company stock worth $118,197,701. 4.60% of the stock is owned by corporate insiders.

Stryker Profile

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan. The company develops and manufactures products used by hospitals, physicians and other healthcare providers across a range of medical specialties.

Stryker's principal businesses include orthopaedics, medical and surgical equipment, and neurovascular products. Its offerings include joint replacement and trauma implants, spinal devices, surgical instruments, operating-room equipment, endoscopy systems, surgical navigation technologies, emergency-care products and devices used to treat neurovascular conditions such as stroke.

Founded in 1941 by Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.